ATIN: Q3 sales soared but losses deepened; board proposes share redemption and delisting

About this update from Athanase Innovation Ab

Net sales surged year-over-year, driven by Ivisys, but Q3 saw a negative operating result due to security value declines and one-off costs. Board proposes a major share redemption and plans to delist, while maintaining strong liquidity and focusing on Ivisys growth.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Athanase Innovation Ab